Your browser doesn't support javascript.
loading
Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives.
Bahreyni, Amirhossein; Khazaei, Majid; Rajabian, Majid; Ryzhikov, Mikhail; Avan, Amir; Hassanian, Seyed M.
Afiliación
  • Bahreyni A; Faculty of Medicine, Department of Clinical Biochemistry and Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.
  • Khazaei M; Faculty of Medicine, Department of Medical Physiology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rajabian M; Department of Biochemistry, Payam-e-Noor University, Mashhad, Iran.
  • Ryzhikov M; Division of Pulmonary and Critical Care Medicine, Washington University, School of Medicine, Saint Louis, MO, USA.
  • Avan A; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Hassanian SM; Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
J Pharm Pharmacol ; 70(2): 191-196, 2018 Feb.
Article en En | MEDLINE | ID: mdl-29057476

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Purinérgicos P1 / Inhibidores de la Angiogénesis / Inductores de la Angiogénesis / Agonistas del Receptor Purinérgico P1 / Antagonistas de Receptores Purinérgicos P1 / Neoplasias / Neovascularización Patológica Límite: Animals / Humans Idioma: En Revista: J Pharm Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Purinérgicos P1 / Inhibidores de la Angiogénesis / Inductores de la Angiogénesis / Agonistas del Receptor Purinérgico P1 / Antagonistas de Receptores Purinérgicos P1 / Neoplasias / Neovascularización Patológica Límite: Animals / Humans Idioma: En Revista: J Pharm Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Irán